| P50 | author | Josefina Piñón Hofbauer | Q59689406 |
| | John Mcgrath | Q72104357 |
| P2093 | author name string | Andrew P South | |
| | Jouni Uitto | |
| | Cristina Has | |
| | Leena Bruckner-Tuderman | |
| | Mei Chen | |
| | Qiujie Jiang | |
| | Marco Prisco | |
| | Christina Gruber | |
| | Velina S Atanasova | |
| P2860 | cites work | Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa | Q45855535 |
| | Mechanism of the action of amoxanox (AA-673), an orally active antiallergic agent | Q46876547 |
| | The COL7A1 mutation database. | Q48643475 |
| | Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model | Q49132534 |
| | High-affinity binding of the NC1 domain of collagen VII to laminin 5 and collagen IV. | Q50335736 |
| | Collagen VII Half-Life at the Dermal-Epidermal Junction Zone: Implications for Mechanisms and Therapy of Genodermatoses. | Q53171208 |
| | Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression. | Q53241307 |
| | Gentamicin enhanced production of hydrogen peroxide by renal cortical mitochondria. | Q53836950 |
| | Identification of the glycine-to-arginine substitution G2043R in type VII collagen in a family with dominant dystrophic epidermolysis bullosa from Hungary. | Q53924976 |
| | Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa | Q84077643 |
| | Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay | Q24323275 |
| | Progress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015 | Q26775276 |
| | NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats | Q28297394 |
| | A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays | Q28534305 |
| | Novel small molecules potentiate premature termination codon readthrough by aminoglycosides | Q28828711 |
| | Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa. | Q30650123 |
| | Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin | Q33699590 |
| | Structural origins of gentamicin antibiotic action | Q33889995 |
| | Translational termination efficiency in mammals is influenced by the base following the stop codon. | Q34222816 |
| | Bone marrow transplantation for recessive dystrophic epidermolysis bullosa | Q34256616 |
| | An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice | Q34327061 |
| | A post-translational regulatory switch on UPF1 controls targeted mRNA degradation | Q34342871 |
| | Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression | Q34362040 |
| | Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system | Q34362841 |
| | Olfactory receptor pseudo-pseudogenes | Q34543334 |
| | Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs | Q34611079 |
| | Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification | Q34660939 |
| | PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia | Q34835916 |
| | Evidence of abundant stop codon readthrough in Drosophila and other metazoa | Q35581562 |
| | Glycine substitutions in the triple-helical region of type VII collagen result in a spectrum of dystrophic epidermolysis bullosa phenotypes and patterns of inheritance. | Q35881816 |
| | Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain | Q36382726 |
| | Rescue of nonsense mutations by amlexanox in human cells | Q36581500 |
| | The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells | Q36688177 |
| | Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124). | Q36907558 |
| | Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells | Q37082009 |
| | Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa | Q37640771 |
| | Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa | Q38385390 |
| | Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa | Q39044711 |
| | Antisense Oligonucleotide-mediated Exon Skipping as a Systemic Therapeutic Approach for Recessive Dystrophic Epidermolysis Bullosa | Q39277650 |
| | Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector | Q39904940 |
| | Supramolecular interactions in the dermo-epidermal junction zone: anchoring fibril-collagen VII tightly binds to banded collagen fibrils | Q40454600 |
| | Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa | Q40690917 |
| | SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa | Q41811020 |
| | Collagen VII plays a dual role in wound healing | Q41843053 |
| | Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa | Q41868932 |
| | Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue | Q41956259 |
| | Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. | Q42445332 |
| | The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations. | Q42605404 |
| | Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD. | Q43144151 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | recessive dystrophic epidermolysis bullosa | Q7302398 |
| P304 | page(s) | 1842-1849 | |
| P577 | publication date | 2017-05-24 | |
| P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
| P1476 | title | Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa | |
| P478 | volume | 137 | |